Amélie Anota (Amelie Anota)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Randomized Controlled Trial

Top Venues

JCO oncology practice

Cancer medicine

European journal of cancer care

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Francesco Sparano, Johannes M Giesinger, Gianluca Gaidano, Amélie Anota, Michele Cavo, Alberto Brini, Maria Teresa Teresa Voso, Adriano Venditti, Francesco Perrone, Massimo Di Maio, Mario Luppi, Fréderic Baron, Uwe Platzbecker, Paola Fazi, Marco Vignetti, Fabio Efficace
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. JCO oncology practice (2024)
Francesco Sparano, Johannes M Giesinger, Gianluca Gaidano, Amélie Anota, Michele Cavo, Alberto Brini, Maria Teresa Teresa Voso, Adriano Venditti, Francesco Perrone, Massimo Di Maio, Mario Luppi, Fréderic Baron, Uwe Platzbecker, Paola Fazi, Marco Vignetti, Fabio Efficace
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. JCO oncology practice 20 (3) (2024)
Francesco Sparano, Johannes M Giesinger, Gianluca Gaidano, Amélie Anota, Michele Cavo, Alberto Brini, Maria Teresa Teresa Voso, Adriano Venditti, Francesco Perrone, Massimo Di Maio, Mario Luppi, Fréderic Baron, Uwe Platzbecker, Paola Fazi, Marco Vignetti, Fabio Efficace
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. JCO oncology practice 20 (3) (2024)
Rana El Haidari, Amélie Anota, Linda Abou Abbas, Virginie Nerich
Health-Related Quality of Life of Lebanese Women With Breast Cancer: Protocol for a Prospective Cohort Study. JMIR research protocols 10 (11) (2021)
Guillaume Mouillet, Fabio Efficace, Antoine Thiery-Vuillemin, Emilie Charton, Mieke Van Hemelrijck, Francesco Sparano, Amélie Anota
Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trials. Cancer medicine 9 (20) (2020)
Emilie Charton, Jean-Baptiste Bachet, Pascal Hammel, Jérôme Desramé, Benoist Chibaudel, Romain Cohen, Philippe Debourdeau, Jérome Dauba, Thierry Lecomte, Jean-François Seitz, Christophe Tournigand, Thomas Aparicio, Véronique Guerin-Meyer, Julien Taieb, Julien Volet, Christophe Louvet, Amélie Anota, Franck Bonnetain
Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial. Cancer medicine 8 (11) (2019)
Anne Brédart, Amélie Anota, Julia Dick, Alejandra Cano, Antoine De Pauw, Jean-Luc Kop, Neil K Aaronson, Eveline M A Bleiker, Joan Brunet, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutzler, Sylvie Dolbeault
The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions. European journal of cancer care 29 (1) (2019)